officialstreetpreachers Subscribe
Published: November 8, 2021

4 Canadian doctors gave medical exemptions for jabs and now they’re facing legal trouble

By The Editor

Mon Nov 8, 2021 – 8:38 pm ESTMon Nov 8, 2021 – 8:49 pm EST

OTTAWA (LifeSiteNews) — Four Ontario doctors have become the target of legal action by the College of Physicians and Surgeons of Ontario (CPSO) after refusing to cooperate with an investigation into why they are giving “inappropriate” medical exemptions for the experimental COVID shots.

Dr. Mary O’Connor, along with Dr. Mark Trozzi, Dr. Rochangé Kilian, and Dr. Celeste Jean Thirlwell, became the subjects of a legal filing by the College of Physicians and Surgeons of Ontario last week after they refused to hand over confidential patient information pursuant to an “investigation” by the college into why they granted medical exemptions to patients for the experimental COVID-19 vaccines. The college is asking the Ontario Superior Court to mandate their compliance.

According to the college’s filing against O’Connor, the investigation concerns “her conduct in relation to the COVID-19 pandemic and her completion of medical exemptions for COVID-19 vaccinations and diagnostic testing.”

Instead of releasing the records, the college contends that O’Connor insisted they must first “define COVID-19″ and that she “will not be able to move forward without the College’s precise definition of COVID-19.”

The college also says that O’Connor requested them to “advise if [the college] knows the ingredients of the gene therapy experiments, the so-called vaccinations, being administered to humanity without informed consent.”

The filing in Superior Court, which seeks to mandate that the doctors provide medical charts, patient information, and even allow investigators entry into their offices to copy

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version